Tailoring CAR T cell technology for T cell leukemia
dc.contributor.author | Schorr, Christopher | |
dc.contributor.author | Perna, Fabiana | |
dc.contributor.department | Medicine, School of Medicine | |
dc.date.accessioned | 2024-06-26T17:16:29Z | |
dc.date.available | 2024-06-26T17:16:29Z | |
dc.date.issued | 2023 | |
dc.eprint.version | Final published version | |
dc.identifier.citation | Schorr C, Perna F. Tailoring CAR T cell technology for T cell leukemia. Mol Ther. 2023;31(3):603-604. doi:10.1016/j.ymthe.2023.02.006 | |
dc.identifier.uri | https://hdl.handle.net/1805/41929 | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | |
dc.relation.isversionof | 10.1016/j.ymthe.2023.02.006 | |
dc.relation.journal | Molecular Therapy | |
dc.rights | Publisher Policy | |
dc.source | PMC | |
dc.subject | Adoptive immunotherapy | |
dc.subject | T-cell leukemia | |
dc.subject | Chimeric antigen receptors | |
dc.title | Tailoring CAR T cell technology for T cell leukemia | |
dc.type | Article | |
ul.alternative.fulltext | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014257/ |